Clinical Trials in Colorado

Showing 3161-3180 of 15,592 trials

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

This clinical trial is evaluating a drug called AC676 in participants with Relapsed/Refractory B-cell Malignancies. The main goals of the study are to: * Identify the recommended dose of AC676 that can be given safely to participants * Evaluate the safety profile of AC676 * Evaluate the pharmacokinetics of AC676 * Evaluate the effectiveness of AC676

Relapsed/Refractory B-cell Malignancies

Accutar Biotechnology Inc60 participantsStarted Jun 2023

Denver, Colorado, United States • Sarasota, Florida, United States • Chapel Hill, North Carolina, United States +6 more locations

TERMINATEDPhase 253 miles

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

NCT04519645

The purpose of the study is to evaluate the efficacy of lacosamide (LCM) versus an Active Comparator chosen based on standard of care (StOC) in severe and nonsevere seizure burden (defined as total minutes of electroencephalographic neonatal seizures (ENS) per hour) in neonates with seizures that are not adequately controlled with previous anti-epileptic drug (AED) treatment.

Electroencephalographic Neonatal SeizuresEpilepsy

UCB Biopharma SRL29 participantsStarted Mar 2021

La Jolla, California, United States • Long Beach, California, United States • Los Angeles, California, United States +15 more locations

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Find Trials by Condition in Colorado

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Biobank For MS And Other Demyelinating Diseases

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

AB-1005 Long-Term Follow-up Study

Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study